TABLE OF CONTENTS As filed with the Securities and Exchange Commission on May 3, 2023. Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Addex Therapeutics Ltd (Exact name of registrant as specified in its charter) Switzerland (State or other jurisdiction of incorporation or organization) 2834 (Primary Standard Industrial Classification Code Number) Chemin des Mines 9, CH-1202 Geneva, Switz ...